Corsair Pharma

Corsair Pharma is a pharmaceutical company in the development stage, primarily focused on developing innovative transdermal therapies to improve the therapeutic profiles of drugs and provide patients with superior treatment options. The company is dedicated to developing novel treprostinil prodrugs, administered through a once-daily transdermal patch for the treatment of PAH patients.